Search

everythinglearnresearchcommunity

for

Search:↓

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Spironolactone most effective for hirsutism, but has side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Best hair growth results from combining finasteride and minoxidil.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Geranium sibiricum extract helps hair grow and is more effective than minoxidil but can be toxic in high concentrations.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.